What does this video actually claim?
@weight.shifter describes experiencing a weight loss plateau lasting months while on Wegovy, along with returning food cravings and "food noise." They're questioning whether to continue the medication given these challenges and the financial cost.
The creator doesn't make specific medical claims but expresses frustration with diminished effectiveness. This represents a common experience among GLP-1 users who initially see dramatic results.
Are weight loss plateaus normal on Wegovy?
Yes, plateaus are completely normal and expected with semaglutide treatment. The STEP 1 trial (Wilding et al., NEJM, 2021) showed that while participants achieved 14.9% weight loss at 68 weeks, most of the loss occurred in the first 60 weeks, with minimal additional loss afterward.
The STEP 5 trial demonstrated this plateau effect over 104 weeks. Participants maintained their weight loss but didn't continue losing significantly after the first year. This doesn't mean the drug stopped working. It means your body reached a new equilibrium weight.
What @weight.shifter describes as "food noise" returning matches clinical observations. Some patients report that the appetite suppression effects can diminish over time, though this varies widely between individuals.
Should you stop Wegovy during a plateau?
The data suggests stopping is usually a mistake. The STEP 1 withdrawal study found that participants who discontinued semaglutide regained 66% of their lost weight within 20 weeks.
More relevant to @weight.shifter's situation: the STEP 5 extension study showed that people who continued treatment maintained their weight loss even during plateau periods. Those who stopped treatment consistently regained weight.
Financial concerns are valid since Wegovy costs around $1,300 monthly without insurance. But if you can afford it and you've achieved meaningful weight loss, the evidence supports continuation for weight maintenance rather than hoping for continued dramatic losses.
What are the options during a plateau?
Your doctor might consider several approaches, though none are guaranteed to restart dramatic weight loss. Dose optimization sometimes helps, though many patients are already on the maximum 2.4mg weekly dose.
Some physicians discuss switching to tirzepatide (Mounjaro/Zepbound), which showed superior weight loss in head-to-head comparisons. The SURMOUNT-2 trial found 15.7% weight loss with tirzepatide versus 3.3% with placebo at 72 weeks.
Lifestyle interventions become more important during plateaus. The medications work best combined with dietary changes and exercise, not as standalone solutions. @weight.shifter doesn't mention whether they've adjusted these factors.
What should you actually know?
Weight loss plateaus don't mean Wegovy has stopped working. The drug continues suppressing appetite and slowing gastric emptying even when the scale doesn't move. Think of it as weight maintenance medication during plateau periods.
The "sweet tooth coming back" that @weight.shifter mentions is real. Some patients develop tolerance to the appetite suppression effects, though this isn't universal. Clinical studies show wide individual variation in response duration.
Most importantly, don't make medication decisions based on short-term frustration. The clinical trials tracked patients for 1-2 years specifically because plateaus are normal parts of the weight loss journey with GLP-1 medications.